Clinical Trial Details

Trial ID: L0717
Source ID: IRCT20191015045113N1
Associated Drug: Zinc
Title: Effect of zinc supplementation on serum zinc status, lipid profile, liver enzymes (ALT, AST), insulin resistance, inflammatory markers and oxidative stress in non-alcoholic fatty liver patients
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: Non Alcoholic Fatty Liver Disease. <br>Fatty (change of) liver, not elsewhere classified;K76.0
Interventions: Intervention 1: Intervention group: Twenty - five patients with ultrasound - confirmed non - alcoholic fatty liver disease received a coated capsule containing 30 mg of Nature Made made at the Faculty of Pharmacy of Shiraz University of Medical Sciences f
Outcome Measures: Serum zinc. Timepoint: 8 weeks. Method of measurement: Blood sampling.;Insulin resistance. Timepoint: 8 weeks. Method of measurement: Blood sampling.;ALT. Timepoint: 8 Week. Method of measurement: blood sample.Fasting blood sugar. Timepoint: 8 week. Method of measurement: blood sample.;Serum total cholesterol. Timepoint: 8 week. Method of measurement: blood sample.;Serum triglyceride. Timepoint: 8 Week. Method of measurement: blood sample.;MDA. Timepoint: 8 week. Method of measurement: blood sample.;Total Antioxidant Capacity (TAC). Timepoint: 8 week. Method of measurement: blood sample.;Hs-CRP. Timepoint: 8 week. Method of measurement: blood sample.
Sponsor/Collaborators: Shiraz University of Medical Sciences
Gender: All
Age: 18 years70 years
Phases: Phase 3
Enrollment: 50
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Samples were included in this study by simple randomization. In this way, patients were randomly assigned to one of th
Start Date: 08/12/2019
Completion Date: --
Results First Posted: --
Last Update Posted: 17 December 2019
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/43583